CURAXIS PHARMACEUTICAL Corp - FORM 8-K - EX-17.2 - RESIGNATION LETTER OF DAVID CORCORAN - June 30, 2011

Attached files

file filename
8-K - CURRENT REPORT - CURAXIS PHARMACEUTICAL Corpasch_8k.htm
EX-17.1 - RESIGNATION LETTER OF PATRICK SMITH - CURAXIS PHARMACEUTICAL Corpasch_ex171.htm
EX-17.5 - RESIGNATION LETTER OF RONALD POMPEO - CURAXIS PHARMACEUTICAL Corpasch_ex175.htm
EX-17.3 - RESIGNATION LETTER OF SHELDON GOLDBERG - CURAXIS PHARMACEUTICAL Corpasch_ex173.htm
EX-99.1 - PRESS RELEASE - CURAXIS PHARMACEUTICAL Corpasch_ex991.htm
EX-3.1 - SECOND AMENDED AND RESTATED BYLAWS - CURAXIS PHARMACEUTICAL Corpasch_ex31.htm
EX-17.4 - RESIGNATION LETTER OF WILLIAM MCCONVILLE - CURAXIS PHARMACEUTICAL Corpasch_ex174.htm
 
Exhibit 17.2
 
 
June 24, 2011
 
Curaxis Pharmaceutical, Corp.
51 Berkshire Street
Swampscott, MA 01907

 
Gentlemen:
 
This letter confirms that I, David J. Corcoran, hereby resign my positions as Executive Vice President, Chief Financial Officer, Director and all other positions to which I have been assigned, regardless of whether I served in such capacity, of the Company, effectively immediately. My resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies (including accounting or financial policies) or practices.
 
Sincerely,

 
 
 /s/ David Corcoran  
David J. Corcoran  
 

CURAXIS PHARMACEUTICAL Corp Reports

Also read